Biotech

Premarket on Wednesday, April 20, 2016, development stage biotech company MediciNova, Inc. (NASDAQ:MNOV) reported interim data from its ongoing trial of MN-166 – its lead amyotrophic lateral sclerosis (ALS) candidate. The company lost strength on Tuesday, but could well pick up a market capitalization boost across Wednesday’s session in...

Intro & History on ABBV (NYSE:ABBV) :    In the biotech and medical marijuana arena, we think that ABBV AbbVie Inc. (NYSE ABBV) is an interesting and well known stock to keep an eye on. ABBV is a pharmaceutical development, discovery, manufacturing and sales firm based in Illinois near Chicago, and...

VBI Vaccines, Inc. - Ordinary Shares (NASDAQ:VBIV) just announced the details of its long awaited phase III program in hepatitis B. The program, if successful, will underpin registration applications for VBI's lead hepatitis B asset in the US, Europe and Canada and – as such – its initiation is...

We think Cara Therapeutics (NASDAQ: CARA), a boutique “clinical stage” biotech/biopharma firm which develops novel compounds (including cannabis derived chemicals) for neuropathic pain is worthy of a close look. Cannabis regulation has been relaxing both globally and in the United States and this influences our stance on CARA stock....

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Fluidigm Corp (NASDAQ:FLDM) reported that Adage Capital Management has picked up 1,546,209 of common stock as of 2017-03-13. The acquisition brings the aggregate amount owned by Adage Capital Management to a total of 1,546,209 representing...